|

alpha beta depletion Clinical Trials

1 actively recruiting trial across 1 location

Also known as: α/β CD3+/CD19+ cell depletion

Pipeline

Phase 2: 1

Top Sponsors

  • Mitchell Cairo1

Indications

  • Amegakaryocytic Thrombocytopenia1
  • Kostmann1
  • Severe Aplastic Anemia1
  • Beta-thalassemia1
  • Diamond Blackfan Anemia1

Valhalla, New York1 trial

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

New York Medical College

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.